StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CannaPharmaRx's pe ratio was 1.5× on Jul 31, 2025, against 0.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20251.5×−2.3
2024Dec 31, 20243.9×+3.6
2011Jan 31, 20110.3×+0.0
2010Dec 31, 20100.3×–

More CannaPharmaRx figures

See a number that looks wrong?